Study of ES414 in Metastatic Castration-Resistant Prostate Cancer

NCT02262910 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
35
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Aptevo Therapeutics